Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide) is a powerful weight loss medication, but not everyone can use it safely. Specific health conditions, medication interactions, and personal medical history can disqualify candidates or require careful monitoring. Understanding your eligibility matters before starting any GLP-1 therapy.

Who Should Not Take Wegovy: Key Medical Contraindications

Wegovy carries absolute contraindications—situations where the medication poses serious risk. Patients with a personal or family history of medullary thyroid carcinoma (MTC) should never use semaglutide, since animal studies showed thyroid C-cell tumors at high doses. Similarly, anyone with a history of multiple endocrine neoplasia syndrome type 2 (MEN2) is excluded from treatment because of shared thyroid cancer risk mechanisms.

Severe pancreatitis history is another major red flag. Patients who have experienced acute or chronic pancreatitis must avoid GLP-1 agonists due to the medication's effect on pancreatic function and the risk of recurrence. Additionally, diabetic retinopathy—particularly proliferative forms—requires close evaluation before starting semaglutide, as rapid blood sugar changes can temporarily worsen vision in susceptible individuals.

Pregnancy, Breastfeeding, and Fertility Concerns with Semaglutide

Semaglutide is category C for pregnancy, meaning animal studies showed fetal risk but human data are limited. Women planning pregnancy or currently pregnant should discontinue Wegovy at least two months before conception, as the medication's effect on appetite and metabolism could interfere with adequate nutrition during early pregnancy and fetal development.

Breastfeeding mothers should not use semaglutide because it passes into breast milk and its long-term effects on nursing infants remain unknown. For women of childbearing age, reliable contraception during treatment is essential. PlexusDx clinicians screen for pregnancy status and reproductive plans during the eligibility consultation to ensure safe prescribing.

Medication Interactions and Drug Combinations to Avoid

Semaglutide can delay gastric emptying, which slows how quickly your stomach releases food into the intestines. This mechanism affects the absorption timing of other oral medications, especially those requiring rapid entry into the bloodstream. Birth control pills, antibiotics, and certain heart medications may lose effectiveness if taken alongside semaglutide without proper spacing and dosing adjustments.

Patients taking insulin or insulin-secreting medications like sulfonylureas face increased hypoglycemia (low blood sugar) risk when combined with GLP-1 therapy. These combinations are not absolutely contraindicated but demand close monitoring and frequent dose adjustments by your prescribing clinician. PlexusDx reviews your complete medication list before approval to identify necessary precautions and flag dangerous interactions.

Thyroid Disease, Kidney Function, and Other Health Conditions

Patients with personal or family thyroid cancer history require alternative weight loss approaches, not semaglutide. Non-medullary thyroid disease—such as hypothyroidism or Graves' disease—does not absolutely exclude Wegovy use, but thyroid function must be monitored regularly. Existing thyroid nodules should be evaluated by endocrinology before starting treatment to establish a baseline and rule out malignancy.

Kidney disease affects how your body processes semaglutide metabolites. While mild-to-moderate chronic kidney disease does not prohibit use, severe renal impairment requires dose adjustments or alternative medications. Patients with gallbladder disease history face increased biliary complications risk. PlexusDx gathers kidney function tests (eGFR, creatinine) and liver panels during initial screening to determine safe dosing and frequency for your individual situation.

When PlexusDx Compounded Semaglutide Becomes Your Alternative

If you don't qualify for Wegovy due to cost, insurance denial, or eligibility concerns, PlexusDx compounded semaglutide injections offer a clinician-supervised path forward. PlexusDx sources all medications from licensed 503A compounding pharmacies—meeting strict federal safety and sterility standards—and serves all 50 states without requiring insurance or membership fees. Pricing starts at $149 per month, flat-rate regardless of dose adjustments, so your dose can rise without your price tag changing.

PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after first month), which maps 14 metabolic pathways and 49 peptides to reveal your genetic response patterns to GLP-1 therapy. This test examines key variants like GLP1R rs6923761 and GIPR rs1800437—not standard pharmacogenomics—to predict which GLP-1 medication and dosing approach will work best for your biology. Even if Wegovy is unavailable or unsuitable, personalized compounded semaglutide tailored to your genetics offers an evidence-based, affordable alternative.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I take Wegovy if I have thyroid disease?

Non-medullary thyroid disorders like hypothyroidism may be compatible with semaglutide, but a personal or family history of medullary thyroid carcinoma or MEN2 makes it absolutely contraindicated. Your clinician will review thyroid ultrasound results and TSH levels before approval. PlexusDx screens all thyroid history during eligibility evaluation to protect your safety.

What happens if I take Wegovy while on insulin or sulfonylureas?

Combining semaglutide with insulin-secreting drugs significantly increases hypoglycemia (low blood sugar) risk because both lower glucose levels. These medications are not forbidden together, but they demand frequent blood sugar monitoring, dose adjustments, and close clinician supervision. PlexusDx reviews your diabetes medication regimen and can coordinate adjustments with your primary care provider.

Is Wegovy safe if I'm planning to get pregnant?

No. Semaglutide should be stopped at least two months before attempting conception due to limited pregnancy safety data and effects on nutrition and metabolism. If you are on Wegovy and planning parenthood, discuss timing with your doctor and switch to non-medication weight management strategies. PlexusDx screens reproductive plans during consultation to ensure appropriate counseling.

Can I use Wegovy with kidney disease?

Mild-to-moderate kidney disease may allow semaglutide use with dose monitoring, but severe renal impairment requires alternative approaches or significant adjustments. PlexusDx obtains kidney function labs (eGFR, creatinine) during screening to determine safety and customize dosing for your kidney health status.

What if I don't qualify for Wegovy but still want semaglutide therapy?

PlexusDx compounded semaglutide injections are available without insurance, starting at $149/month from licensed 503A pharmacies, and serve all 50 states. Add the Precision Peptide Genetic Test to discover your individual GLP-1 response profile across 14 metabolic pathways and 49 peptides—revealing whether semaglutide, tirzepatide, or a dual compound suits your genetics best.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves